Henry Schein Inc

Financials

Cash from operating activities 598.91 M709.58 M602 M500 M848 M712 M 712 M Cash from investing activities -115.02 M-677.22 M-276 M-1.14 B-430 M-400 M -400 M Cash from financing activities -187.19 M-332.96 M-315 M701 M-510 M-188 M -188 M Free cash flow 550.08 M630.57 M506 M353 M700 M573 M 573 M

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners.

HSIC

Financials

Henry Schein Inc

Notícias

Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

What to Expect From Henry Schein’s Q1 2026 Earnings Report

Conselho da Henry Schein será reduzido para 10 membros após assembleia anual

Should You Retain Henry Schein Stock in Your Portfolio for Now?

ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?

Align Technology: Only International Growth Can Save Them Now (Downgrade) (NASDAQ:ALGN)

Principais ações de tecnologia médica, segundo Piper Sandler

Henry Schein na conferência da Barclays: expansão digital e ganhos de mercado

Henry Schein at Barclays Conference: Digital Expansion and Market Gains

Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Leerink Partners reitera classificação das ações da Henry Schein com preço-alvo de US$ 87

Leerink Partners reiterates Henry Schein stock rating at $87 target